|
?:authorAffiliation
|
-
[\'NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.\', \'Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.\', \'TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany.\', \'Helmholtz-Institute for RNA-based Infection Research (HIRI), Würzburg, Germany.\', \'Pharmaceutical Biotechnology, University of Tübingen, Tübingen, Germany.\', \'Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.\', \'German Center for Diabetes Research (DZD), München-Neuherberg, Germany.\', \'Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Niedersächsisches Landesgesundheitsamt, Department of Virology/Serology, Hannover, Germany.\', \'Institute of Virology, Saarland University Medical Center, Homburg/Saar, Germany.\', \'Department of Gastroenterology, Hepatology, Endocrinology, Hannover Medical School, Hannover, Germany; Centre for Individualized Infection Medicine (CiiM), Hannover, Germany.\', \'Hannover Unified Biobank (HUB), Hannover Medical School, Hannover, Germany.\', \'Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.\', \'Biomedical Research in End-stage and obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.\', \'Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.\', \'Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.\', \'German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies\', University of Tübingen, Tübingen, Germany.\', \'Department of Women\'s Health, Research Institute for Women\'s Health, Eberhard-Karls-University, Tübingen, Germany.\', \'Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.\', \'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) and Robert Bosch Center for Tumor Diseases (RBCT), both Stuttgart, Germany.\', \'NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. Nicole.Schneiderhan@nmi.de.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}